WallStreetZenWallStreetZen

NASDAQ: HLVX
Hillevax Inc Stock Forecast, Predictions & Price Target

Analyst price target for HLVX

Based on 3 analysts offering 12 month price targets for Hillevax Inc.
Min Forecast
$28.00+122.58%
Avg Forecast
$30.67+143.78%
Max Forecast
$34.00+170.27%

Should I buy or sell HLVX stock?

Based on 3 analysts offering ratings for Hillevax Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HLVX stock forecasts and price targets.

HLVX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21
lockedlocked$00.00+00.00%2023-11-15
lockedlocked$00.00+00.00%2023-11-10

1 of 1

Forecast return on equity

Is HLVX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is HLVX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

HLVX revenue forecast

What is HLVX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$12.5M
Avg 2 year Forecast
$110.0M
Avg 3 year Forecast
$266.6M

HLVX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HLVX$12.58$30.67+143.78%Strong Buy
CABA$12.96$34.33+164.92%Strong Buy
DNTH$21.32$41.75+95.83%Strong Buy
PROK$2.71$2.50-7.75%Hold
MESO$6.22N/AN/A

Hillevax Stock Forecast FAQ

Is Hillevax Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: HLVX) stock is to Strong Buy HLVX stock.

Out of 3 analysts, 2 (66.67%) are recommending HLVX as a Strong Buy, 1 (33.33%) are recommending HLVX as a Buy, 0 (0%) are recommending HLVX as a Hold, 0 (0%) are recommending HLVX as a Sell, and 0 (0%) are recommending HLVX as a Strong Sell.

If you're new to stock investing, here's how to buy Hillevax stock.

What is HLVX's revenue growth forecast for 2026-2028?

(NASDAQ: HLVX) Hillevax's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Hillevax's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast HLVX's revenue for 2026 to be $621,260,350, with the lowest HLVX revenue forecast at $621,260,350, and the highest HLVX revenue forecast at $621,260,350. On average, 2 Wall Street analysts forecast HLVX's revenue for 2027 to be $5,469,079,113, with the lowest HLVX revenue forecast at $1,570,546,165, and the highest HLVX revenue forecast at $9,367,612,061.

In 2028, HLVX is forecast to generate $13,248,053,908 in revenue, with the lowest revenue forecast at $2,186,836,432 and the highest revenue forecast at $26,261,917,515.

What is HLVX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: HLVX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is HLVX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year HLVX price target, the average HLVX price target is $30.67, with the highest HLVX stock price forecast at $34.00 and the lowest HLVX stock price forecast at $28.00.

On average, Wall Street analysts predict that Hillevax's share price could reach $30.67 by Mar 21, 2025. The average Hillevax stock price prediction forecasts a potential upside of 143.78% from the current HLVX share price of $12.58.

What is HLVX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: HLVX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.